Advances in Drug Delivery Systems and Applications in Neurosurgery

  • Y. Lazorthes
  • B. Sallerin-Caute
  • J. C. Verdie
  • R. Bastide
Part of the Advances and Technical Standards in Neurosurgery book series (NEUROSURGERY, volume 18)


The principle of direct administration of repeated doses of drugs either at or close to their site of action in the central nervous system is based on:
  • the identification of specific receptors and neuro-active endogenous peptides which has considerably advanced our understanding of the functioning of the central nervous system. The notion of chemical transmission of information in specific pathways now underlies the early electrical model of Galvani.

  • better understanding of the pharmacological action of endogenous and exogenous ligands, which was led to the development of specific and highly active drugs. Such drugs are now employed routinely in the treatment of chronic conditions such as intractable pain or spasticity. In the near future, it may also be possible to treat other neurological diseases by manipulation of the specific neuromediators or neuromodulators involved.

  • the fact that high doses of drug are often required via the systemic route, giving rise to adverse reactions in other parts of the organism before the active agent reaches the target organ. Many drugs do not readily cross the blood-brain barrier, and are degraded in the periphery either in the digestive tract, liver or kidneys. This means that the therapeutic ratio is low for many drugs. Moreover, distribution in the central nervous system itself is not localized to the site of action (spinal cord for example) which can give rise to supra-spinal side effects.

  • advances in technology which have stimulated development of implantable systems enabling local or regional administration of many drugs employed in endocrinology, oncology and neurology.


Drug Delivery System Access Port Intrathecal Administration Intrathecal Morphine Intrathecal Baclofen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Akaike A, Shibata T, Satoh M, Takagi H (1978) Analgesia induced by microinjection of morphine into an electrical stimulation of the nucleus reticularis paragigantocellularis of the rat medulla oblongata. Neuropharmacology 17: 775–778PubMedGoogle Scholar
  2. 2.
    Atweh SF, Kuhar MJ (1977) Autoradiographic localization of opiate receptors in rat brain. I. Spinal cord and lower medulla. Brain Res 124: 53–67PubMedGoogle Scholar
  3. 3.
    Atweh SF, Kuhar MJ (1977) Autoradiographic localization of opiate receptors in rat brain. II. The brain stem. Brain Res 129: 1–12PubMedGoogle Scholar
  4. 4.
    Auer LM, Ito Z, Zuzuki A, Otha H (1982) Prevention of symptomatic vasospasm by topically applied nimodipine. In: Auer LM et al (eds) Proc 1st Int Symp Aneurysm surgery in the acute stage. Acta Neurochir (Wien) 63: 297–302Google Scholar
  5. 5.
    Auer LM, Suzuki A, Yasui N, Ito Z (1984) Intraoperative topical nimodipine after aneurysm clipping. Neurochirurgia 27: 36–38PubMedGoogle Scholar
  6. 6.
    Ballantine P (1984) Intraventricular lithium infusion and potential applications in psychiatry. In: A professional briefing on “Totally implantable pumps”. Isle of Palms, South Carolina, Sept 19–22Google Scholar
  7. 7.
    Beck DO (1984) Continuous infusion of methotrexate therapy of meningeal carcinomatosis. In: A professional briefing on “Totally implantable pumps”. Isle of Palms, South Carolina, Sept 19–22Google Scholar
  8. 8.
    Blackshear P (1979) Implantable drug delivery systems. Scientific American 241: 66–73PubMedGoogle Scholar
  9. 9.
    Blond S (1989) Morphinothérapie intra-cérébro-ventriculaire. A propos de 79 cas. Neurochirurgie 35: 52–57PubMedGoogle Scholar
  10. 10.
    Blond S, Dubar M, Meynadier J, Combelles J, Pruvot M, Vitrac P (1985) Cerebral intraventricular administration of morphine in cancer patients with intractable pain. The Pain Clinic 1: 77–79Google Scholar
  11. 11.
    Bosch DA, Hindmarsch TH, Larsson ST, Backlund EO (1980) Intraneoplastic administration of bleomycin in intracerebral glioma: A pilot study. Acta Neurochir (Wien) [Suppl] 30: 444Google Scholar
  12. 12.
    Bouhassira D, Villanueva L, Le Bars D (1986) Effects of intraventricular (i.c.v.) morphine upon diffuse noxious inhibitory controls (DNIC) in the rat. Neurosci Lett 26: 5410Google Scholar
  13. 13.
    Bouhassira D, Villanueva L, Le Bars D (1988) Intra-cerebroventricular morphine restores the basic somesthetic activity of dorsal horn convergent neurones in the rat. Eur J Pharmacol 148: 273–277PubMedGoogle Scholar
  14. 14.
    Bouvier G, Penn RD, Kroin JS, Beigue R, Guerard MJ (1986) Direct delivery of medication into a brain tumour through multiple chronically implanted catheters. Neurosurgery 20: 286–291Google Scholar
  15. 15.
    Bowery NG, Hill DR, Hudson AL et al (1980) Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor. Nature 283: 92–94PubMedGoogle Scholar
  16. 16.
    Bowery NG, (1982) Baclofen 10 years on. TIPS, 400–403Google Scholar
  17. 17.
    Caute B, Monsarrat B, Gouardères CH, Verdié JC, Lazorthes Y, Cros J, Bastide R (1988) CSF morphine levels and analgesia after lumbar intrathecal administration of isobaric and hyperbaric solutions in humans. Pain 32: 141–146PubMedGoogle Scholar
  18. 18.
    Chauvon M, Samii K, Schermann JM, Sandouk P, Bourbon R, Viars P (1981) Plasma concentration after I. M., extradural and intrathecal administration. Br J Anaesth 53: 911–913Google Scholar
  19. 19.
    Conseiller C, Menetrey D, Le Bars D, Besson JM (1972) Effet de la morphine sur les activites des interneurones de la couche V de Rexed de la corne dorsale chez le chat spinal. J Physiol 65: 220Google Scholar
  20. 20.
    Cook WA, Weinstein SP (1973) Chronic dorsal column stimulation in multiple sclerosis. NY State J Med 73: 2868–2872Google Scholar
  21. 21.
    Coombs DW, Saunders RL, Gaylor M, Pageau MG (1982) Epidural narcotic infusion reservoir implantation technique and efficacy. Anesthesiology 56: 469–473PubMedGoogle Scholar
  22. 22.
    Cooper IS (1973) Effect of chronic stimulation of anterior cerebellum on neurological diseases. Lancet 1: 206 (letter)PubMedGoogle Scholar
  23. 23.
    Coyle JT, Price DL, Delong MR (1983) Alzheimer’s disease: a disorder of cortical cholinergic innervation. Science 219: 1184–1190PubMedGoogle Scholar
  24. 24.
    Crafts DC, Levin VA, Nielsen SA (1976) Intracarotid BCNU (NSC-409962): a toxicity study in six rhesus monkeys. Cancer Treat Rep 60: 541–545PubMedGoogle Scholar
  25. 25.
    Crawford ME, Anderson HB, Augustenburg G, Bay J, Beck O, Benveniste D, Larsen LB, Carl P, Djeines M, Eriksen J, Grell AM, Henriksen H, Johansen SH, Jorgensen HOK, Moller IW, Pedersen JEP, Raulo O (1983) Pain treatment on out patient basis utilizing extradural opiates. A danish multicenter study comprising 105 patients. Pain 16: 41–47PubMedGoogle Scholar
  26. 26.
    Dakhil S, Ensminger W, Kindt G, Niedorhuber J, Chandler W, Greenburg H, Wheeler R (1981) Implanted system for intraventricular drug infusion in central nervous system tumours. Cancer Treat Rep 65: 401–411PubMedGoogle Scholar
  27. 27.
    Davidoff RA, Sears ES (1974) The effects of Lioresal on synaptic in the isolated spinal cord. Neurology 24: 957–963PubMedGoogle Scholar
  28. 28.
    Davies P (1979) Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Brain Res 171: 319–327PubMedGoogle Scholar
  29. 29.
    Davis R, Gray EF (1980) Technical problems and advances in the cerebellarstimulating systems used for reduction of spasticity and seizures. Appl Neurophysiol 43: 230–243PubMedGoogle Scholar
  30. 30.
    Devulder J, De Colvenaer L, De Somer R, Dumoulin K, Rolly G, Capiau P (1989) L’administration d’opiacées spinales: revue de vingt patients. Douleur et Analgésie 11: 131–137Google Scholar
  31. 31.
    Dickenson AH, Oliveras JL, Besson JM (1979) Role of the nucleus raphe magnus in opiate analgesia as studied by the microinjection technique in the rat. Brain Res 170: 95–111PubMedGoogle Scholar
  32. 32.
    Dickenson AH, Le Bars D (1983) Morphine micro injections into periaqueductal grey matter of the rat: effect on dorsal horn neuronal responses to C fibre activity and diffuse noxious activity controls. Life Sci 33: 549–554PubMedGoogle Scholar
  33. 33.
    Duggan AW, Hall JG, Headly PM (1977) Suppression of transmission of nociceptive impulses by morphine selective effects of morphine administered in the regions of the substantia gelatinosa. Br J Pharmacol 61: 65–76PubMedGoogle Scholar
  34. 34.
    Erickson DL, Blacklock JB, Michaelson M et al (1985) Control of spasticity by implantable continuous flow morphine pump. Neurosurgery 16: 215–217PubMedGoogle Scholar
  35. 35.
    Fenstermacher JD, Cowles AL (1977) Theoretic limitation of intracarotid infusions in brain tumour chemotherapy. Cancer Treat Rep 61: 519–526PubMedGoogle Scholar
  36. 36.
    Feun LG, Wallace S, Stewart DJ, Chuang WP, Yung WKA, Leavens ME, Burgess MA, Savaraj N, Benjamin RS, Young SE, Tang RA, Handel S, Mavligit G, Fields ES (1984) Intracarotid infusion of cisdiamminedichloroplatinum in the treatment of recurrent malignant brain tumours. Cancer 54: 794–799PubMedGoogle Scholar
  37. 37.
    Fiume D, Piccini M, Tamorri M (1985) Two years experience of iterative intrathecal morphine for cancer pain. In: Besson JM, Lazorthes Y (eds) Spinal opioids and the relief of pain. INSERM Editions, ParisGoogle Scholar
  38. 38.
    Foerster O (1913) On the indications and results of the excision of posterior spinal nerve root in men. Surg Gynecol Obstet 16: 463–474Google Scholar
  39. 39.
    Garfield J, Dayan AD (1973) Post-operative intracavitary chemotherapy of malignant gliomas: a preliminary study using methotrexate. J Neurosurg 39: 315–322PubMedGoogle Scholar
  40. 40.
    Glynn CJ, Mather LE, Consins MJ, Wilson PR, Graham JR (1979) Spinal narcotics and respiratory depression. The Lancet 1: 356–357Google Scholar
  41. 41.
    Greenberg HS, Ensminger WD, Seeger JF, Kindt GW, Chandler F, Doan K, Dakhil SR (1981) Intra-arterial BCND chemotherapy for the treatment of malignant gliomas of the central nervous system: a preliminary report. Cancer Treat Rep 65: 803–810PubMedGoogle Scholar
  42. 42.
    Greenberg HS (1984) Intra-arterial chemotherapy for malignant tumours of the central nervous system. In: A professional briefing on “Totally implantable pumps”, Isle of Palms, South Carolina, Sept 19–22Google Scholar
  43. 43.
    Hankey GJ, Stewart-Wynne EG, Perlman D (1986) Intrathecal baclofen for severe spasticity. Med J Aust 145: 465–466PubMedGoogle Scholar
  44. 44.
    Harbaugh RE, Roberts DW, Coombs DW, Saunders RL, Reeder TM (1984) Preliminary report: intracranial cholinergic drug infusion in patients with Alzheimer’s disease. Neurosurgery 15: 514–518PubMedGoogle Scholar
  45. 45.
    Harbaugh RE (1986) Intracranial drug administration in Alzheimer’s disease. Psychopharmacol Bull 22: 106–109PubMedGoogle Scholar
  46. 46.
    Harbaugh RE (1987) Intracerebroventricular cholinergic drug administration in Alzheimer’s disease: Preliminary results of a double blind study. J Neurotransm 24 [Suppl] 271–277Google Scholar
  47. 47.
    Harbaugh RE, Dempsey PK, Nierenberg DW, Maurer LH, Reeder TM (1988) Phase I study of intratumoural methotrexate infusion in malignant brain tumours. Presented at the New England Neurosurgical Society Meeting, Woodstock VT, March 4, 1988Google Scholar
  48. 48.
    Harbaugh RE, Saunders RL, Reeder RF (1988) Use of implantable pumps for central nervous system drug infusions to treat neurological disease. Neurosurgery 23: 693–698PubMedGoogle Scholar
  49. 49.
    Hayes RL, Price DD, Ruda M, Dubner R (1979) Suppression ofnociceptive responses in the primate by electrical stimulation of the brain or morphine administration: behavioural and electrophysiological comparisons. Brain Res 167: 417–421PubMedGoogle Scholar
  50. 50.
    Hefti F, Werner WJ (1986) Nerve growth factor and Alzheimer’s disease. Ann Neurol 20: 275–281PubMedGoogle Scholar
  51. 51.
    Hood TW, Domino DF, Greenberg HS (1987) Possible treatment of Parkinson’s disease with intrathecal medication: MPTP model. Presented at the New York Academy of Sciences, New York, NY, June 13, 1987Google Scholar
  52. 52.
    Hughes J (1975) Isolation of an endogenous compound from brain with pharmacological properties similar to morphine. Brain Res 88: 295–308PubMedGoogle Scholar
  53. 53.
    Kasdon DL (1986) Controversies in the surgical management of spasticity. Clin Neurosurg 33: 523–529PubMedGoogle Scholar
  54. 54.
    Kerr DIB, Ong J, Prager RH et al (1987) Phaclofen: a peripheral and control baclofen antagonist. Brain Res 405: 150–154PubMedGoogle Scholar
  55. 55.
    Knuttsson E (1983) Analysis of gait and isokinetic movements for evaluation of antispastic drugs or physical therapies. In: Desmedt JE (eds) Motor control mechanisms in health and disease. Raven Press, New York, pp 1013–1034Google Scholar
  56. 56.
    Knuttsson E, Lindbiom U, Martensson A (1987) Plasma and cerebrospinal fluid levels of baclofen (Lioresal) at optimal therapeutic responses in spastic paresis. J Neurol Sei 23: 473–484Google Scholar
  57. 57.
    Kroin JS., Penn RD (1982) Intracerebral chemotherapy: chronic microinfusion of cisplatin. Neurosurgery 10: 349–354PubMedGoogle Scholar
  58. 58.
    Kroin JS, Penn RD, Beissinger RL et al (1984) Reduced spinal reflexes following intrathecal baclofen in the rabbit. Exp Brain Res 54: 191–194PubMedGoogle Scholar
  59. 59.
    Latash ML, Penn RD, Corcos DM, Gottlieb GL (1990) Effects ofintrathecal baclofen on voluntary motor control in spastic patients. J Neurosurg 72: 388–392PubMedGoogle Scholar
  60. 60.
    Lazorthes Y, Gouardères CH, Verdié JC, Monsarrat B, Bastide R, Campan L, Cros J (1980) Analgésie par injection intrathécale de morphine. Etude pharmacocinetique et application aux dou1eurs irréductibles. Neurochirurgie 26A: 159–164Google Scholar
  61. 61.
    Lazorthes Y, Siegfried J, Gouarderes CH, Bastide R, Cros J, Verdié JC (1983) Periventricular grey matter stimulation versus chronic intrathecal morphine in cancer pain. In: Bonica JJ (ed) Advances in pain research and therapy, vo15. Raven Press, New York, pp 467–475Google Scholar
  62. 62.
    Lazorthes Y (1984) Chronic cerebellar cortex stimulation for grades spastic cerebral palsy patients. In: Davis R, Bloedel JR (eds) Cerebellar stimulation for spasticity and seizures. CRC Press, New York, pp 217–220Google Scholar
  63. 63.
    Lazorthes Y, Verdié JC, Bastide R, Lavados A, Descouens D (1985) Spinal versus intraventricular chronic opiate administration with implantable drug delivery devices for cancer pain. Appl Neurophysiol 48: 234–241PubMedGoogle Scholar
  64. 64.
    Lazorthes Y, Verdié JC, Bastide R, Clergue ML, Lavados A, Caute B, Cros J (1985) Chronic spinal administration of opiate: application in the treatment of intractable cancer pain. In: Besson JM, Lazorthes Y (eds) Spinal opioids and the relief of pain: Basic mechanisms and clinical applications, Vol 127. INSERM Editions, Paris, pp 437–463Google Scholar
  65. 65.
    Lazorthes Y, Verdié JC, Bastide R, Caute B, Clemente G (1985) Les systèmes implantables pour administration épidurale et intrathecale d’opioides. In: Besson JM, Lazorthes Y (eds) Spinal opioids and the reliefofpain. INSERM Editions, ParisGoogle Scholar
  66. 66.
    Lazorthes Y (1985) Neuropharmacological en application intrathécale. Neurochirurgie 31 [Suppl 1]: 95–101Google Scholar
  67. 67.
    Lazorthes Y (1988) Chronic intrathecal administration of baclofen in treatment of severe spasticity. In: Müller H, Zierski J, Penn RD (eds) Local spinal therapy of spasticity. Springer, Berlin Heidelberg New York Tokyo, pp 215–222Google Scholar
  68. 68.
    Lazorthes Y (1986) Morphinotherapie intrathecale chez l’homme. Rec Med Vet 162: 1409–1419Google Scholar
  69. 69.
    Lazorthes Y, Verdié JC, Caute B, Maranhao R, Tafani M (1988) Intracerebro-ventricular morphinotherapy for control of chronic cancer pain. In: Fields HL, Besson JM (eds) Progress in brain research. Elsevier Science Publisher 77: 395–405Google Scholar
  70. 70.
    Lazorthes Y, Verdié JC (1988) Implantable systems for local chronic administration of drugs. Applications in neuropharmacology. In: Pluchino F, Broggi G (eds) Advanced technology in neurosurgery. Springer, Berlin Heidelberg New York Tokyo, pp 214–235Google Scholar
  71. 71.
    Lazorthes Y, Sallerin-Caute B, Verdié JC, Bastide R, Carillo JP (1990) Chronic intrathecal baclofen administration for control of severe spasticity. J Neurosurg 72: 393–402PubMedGoogle Scholar
  72. 72.
    Leavens ME, Hills CS Jr, Cech DA, Weyland JB, Weston JS (1982) Intrathecal and intraventricular morphine for pain in cancer patients. Initial study. J Neurosurg 56: 241–245PubMedGoogle Scholar
  73. 73.
    Le Bars D, Dickenson AH, Besson JM (1980) Microinjections of morphine within nucleus raphe magnus and dorsal horn neurone activities related to nociception in the rat. Brain Res 189: 467–481PubMedGoogle Scholar
  74. 74.
    Lenzi A, Galli G, Gandolfini M, Marini G (1985) Intraventricular morphine in paraneoplasic painful syndrome of the cervico-facial region: experience in thirty eight cases. Neurosurgery 17: 6–11PubMedGoogle Scholar
  75. 75.
    Lewis VA, Gebhart GF (1977) Evaluation of the periaqueductal central gray (PAG) as a morphine-specific locus of action and examination of morphineinduced and stimulation-produced analgesia at coincident PAG loci. Brain Res 124: 283–303PubMedGoogle Scholar
  76. 76.
    Lobato RD, Madrid JL, Fatela LV, Rivas JJ, Reig E, Lamas E (1983) Intraventricular morphine for control of pain in terminal cancer patients. J Neurosurg 59: 627–633PubMedGoogle Scholar
  77. 77.
    Lobato RD, Madrid JL, Fatela LV, Gozalo A, Rivas JJ, Sarabia R (1985) Analgesia elicited by low-dose intraventricular morphine in terminal cancer patients. In: Fields H et al (ed) Advances in pain research and therapy, Vol 9. Raven Press, New York, pp 673–681Google Scholar
  78. 78.
    Meynadier J, Blond S, Combelles M (1984) Treatment of intractable pain in patients with advanced cancer. Pain [Suppl] 2: S 344Google Scholar
  79. 79.
    Morantz MA (1984) Intraneoplastic chemotherapy in the treatment of primary brain tumour. In: A professional briefing on “Totally implantable pumps”, Isle of Palms, South Carolina, Sept 19–22, 1984Google Scholar
  80. 80.
    Müller H, Borner U, Stoyanov M, Hempelmann G (1982) Theoretical aspects and practical considerations concerning selective opiate analgesia. Spinal Opiate Analgesia 144: 9–17Google Scholar
  81. 81.
    Müller H, Zierski J, Dralle D et al (1987) The effect of baclofen on electrical muscle activity in spasticity. J Neurol 234: 348–352PubMedGoogle Scholar
  82. 82.
    Müller H, Zierski J, Dralle D et al (1988) Intrathecal baclofen in spasticity. In: Müller H, Zierski J, Penn RD (eds) Local spinal therapy of spasticity. Springer, Berlin Heidelberg New York Tokyo, pp 155–214Google Scholar
  83. 83.
    Müller-Schwefe G (1988) Physostigmine reversal of baclofen-induced sedation. In: Müller H, Zierski J, Penn RD (eds) Local spinal therapy of spasticity. Springer, Berlin Heidelberg New York Tokyo, pp 253–254Google Scholar
  84. 84.
    Munsat TL (1984) Intrathecal TRH in motor neuron diseases. In: A professional briefing in “Totally implantable pumps”. Isle of Palms, South Carolina, Sept 19–22, 1984.Google Scholar
  85. 85.
    Munsat TL, Taft J, Kasdon J (1987) Long term intrathecal infusion of TRH in ALS. Presented at the New York Academy of Sciences, New York NY, June 13, 1987Google Scholar
  86. 86.
    Nurchi G (1984) Use of intraventricular an intrathecal morphine in intractable pain associated with cancer. Neurosurgery 15: 801–803PubMedGoogle Scholar
  87. 87.
    Obbens EAMT, Hill CS, Leavens ME, Ruthenbeck SS, Otis F (1987) Intraventricular morphine administration for control of chronic cancer pain. Pain 28: 61–68PubMedGoogle Scholar
  88. 88.
    Onofrio B, Yaksh TL, Arnold PG (1981) Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clin Proc 56: 516–520PubMedGoogle Scholar
  89. 89.
    Penn RD (1982) Chronic cerebellar stimulation of cerebral palsy: a review. Neurosurgery 10: 116–121PubMedGoogle Scholar
  90. 90.
    Penn RD, Paice JA, Gottschalk W, Ivankovitch AD (1984) Cancer pain relief using chronic morphine infusion: early experience with a programmable implanted drug pump. J Neurosurg 61: 302–306PubMedGoogle Scholar
  91. 91.
    Penn RD, Kroin JS (1984) Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1: 1078 (letter)PubMedGoogle Scholar
  92. 92.
    Penn RD, Kroin JS (1985) Continuous intrathecal baclofen for severe spasticity. Lancet 2: 125–127PubMedGoogle Scholar
  93. 93.
    Penn RD, Kroin JS, Harris JE, Chiu KM, Braun DP (1986) Chronic intratumoural chemotherapy of a rat tumour with cisplatin and fluorouracil. Appl Neurophysiol 46: 240–244Google Scholar
  94. 94.
    Penn RD, Kroin JS (1987) Long-term intrathecal baclofen infusion for treatment of spasticity. J Neurosurg 66: 181–185PubMedGoogle Scholar
  95. 95.
    Penn RD, Martin EM, Wilson RS, Fox JH, Savoy SM (1988) Intraventricular bethanechol infusion of Alzheimer’s disease: results of double-blind and escalating dose trials. Neurology 38: 219–222PubMedGoogle Scholar
  96. 96.
    Penn RD (1988) Chronic intrathecal baclofen for severe rigidity and spasms. In: Müller H, Zierski J, Penn RD (eds) Local spinal therapy of spasticity. Springer, Berlin Heidelberg New York Tokyo, pp 151–154Google Scholar
  97. 97.
    Penn RD, Savoy SM, Cordos D et al (1989) Intrathecal baclofen for severe spasticity. N Engl J Med 320: 1517–1521PubMedGoogle Scholar
  98. 98.
    Pert CB, Snyder SM (1973) Opiate receptor: demonstration in nervous tissue. Science 179: 1011–1014PubMedGoogle Scholar
  99. 99.
    Philips TW, Chandler WF, Kindt GW, Ensminger WD, Greenberg HS, Seeger JF, Doan KM, Gyves JW (1982) New implantable continuous administration and bolus dose intracarotid drug delivery system for the treatment of malignant gliomas. Neurosurgery 11: 213–218Google Scholar
  100. 100.
    Price GW, Wilkin GP, Turnbull MJ et al (1984) Are baclofen-sensitive GABA-receptors present on primary afferent terminals of the spinal cord? Nature 307: 71–73PubMedGoogle Scholar
  101. 101.
    Roquefeuil B, Benezech J, Batier C, Blanchet P, Gros C, Mathieu-Daude JC (1983) Intérêt de l’analgésie morphinique par voie ventriculaire dans les algies rebelles néoplasiques. Neurochirurgie 29: 135–141PubMedGoogle Scholar
  102. 102.
    Roquefeuil B, Benezech J, Blanchet P, Batier C, Frerebeau Ph, Gros C (1984) Intraventricular administration for morphine in patients with neoplasic intractable pain. Surg Neurol 21: 155–158PubMedGoogle Scholar
  103. 103.
    Roquefeuil B, Benezech J, Batier C (1985) Intérêt de l’analgésie morphinique par voie ventriculaire dans les algies rebelles neoplasiques. In: Simon L, Roquefeuil B, Pelissier J (eds) Le douleur chronique. Masson, Paris, pp 212Google Scholar
  104. 104.
    Sallerin-Caute B, Monsarrat B, Lazorthes Y et al (1988) A sensitive method for determination of baclofen in human CSF by high performance liquid chromatography. J Liquid Chromatography 11: 1753–761Google Scholar
  105. 105.
    Samii K, Feret J, Harari A, Viars P (1981) Post-operative spinal analgesia with morphine. Br J Anaesth 53: 817–820PubMedGoogle Scholar
  106. 106.
    Saunders RL, Commbs DW (1983) Dartmouth-Hitchcock Medical Center experience with continuous intraspinal narcotic analgesia. In: Schmidek H, Sweet WE (eds) Operative neurosurgical techniques, Vol. 2. Grune and Stratton, New York, pp 1211–1212Google Scholar
  107. 107.
    Schwartz M, Klockgether T, Wullner U et al (1988) Delta-aminovaleric system. Exp Brain Res 70: 618–626Google Scholar
  108. 108.
    Sedan R, Lazorthes Y (eds) (1978) La neurostimulation 6lectrique th6rapeutique. Neurochirurgie 24 [Suppl 1]: 1–125Google Scholar
  109. 109.
    Siegfried J, Lazorthes Y (eds) (1985) La neurochirurgie fonctionnelle de l’infirmite motrice d’origine cerebrale. Neurochirurgie 31 [Suppl 1]: 1–118Google Scholar
  110. 110.
    Siegfried J, Rea GL (1987) Intrathecal application on baclofen in the treatment of spasticity. Acta Neurochir (Wien) [Suppl] 39: 121–23 (1987)Google Scholar
  111. 111.
    Simon EJ (1982) Opiate receptors and opioid peptides: an overview. Ann NY Acad Sci 327–339Google Scholar
  112. 112.
    Sindou M, Fischer G, Goutelle A et al (1974) La radicellotomie postérieure sélective dans le traitement des spasticités. Rev Neurol 130: 201–216PubMedGoogle Scholar
  113. 113.
    Stewart DJ, Grahovac Z, Benoit B, Addison D, Richard MT, Dennery J, Hugenholtz H, Russell N, Peterson E, Maroun JA, Vandenberg T, Hopkins HS (1984) Intracarotid chemotherapy with a combination of 1.3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4’-0-(4.6–0–2-thenylidene-beta-d-glucopyranosyl) epipodrophyllonoxin (VM-26) in the treatment of primary and metastatic brain tumours. Neurosurgery 15: 828–833PubMedGoogle Scholar
  114. 114.
    Tafani M, Danet B, Verdié JC, Lazorthes Y, Esquerré JP, Simon J (1989) Human brain and spinal cord scan after intra-cerebro-ventricular administration of iodine 123 morphine. Nucl Med Biol 16: 505–509Google Scholar
  115. 115.
    Thiebaut JB, Blond S, Farcot JM, Thurel C, Matge G, Schach G, Meynadier J, Bucheit F (1985) La morphine par voie intraventriculaire dans le traitement des douleurs neoplasiques. Med Hyg 43: 636–646Google Scholar
  116. 116.
    Tsou K, Jang CS (1964) Studies on the site of analgesic action of morphine by intracerebral microinjection. Sci Sin 13: 1099–1109PubMedGoogle Scholar
  117. 117.
    Tung AS, Tenicela R, Bart G, Winter P (1982) Intrathecal morphine in cancer patients tolerant to systemic opiates. Spinal Opiate Analgesia 144: 138–140Google Scholar
  118. 118.
    Yaksh TL, Rudy TA (1977) Studies on the direct spinal action of narcotics in the production of analgesia in the rat. J Pharmacol Exp Ther 202: 411–428PubMedGoogle Scholar
  119. 119.
    Yaksh TL, Rudy TA (1978) Narcotic analgetics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques. Pain 4: 299–359PubMedGoogle Scholar
  120. 120.
    Yaksh TL (1978) Analgesic actions of intrathecal opiates in cat and primate. Brain Res 153: 205–210PubMedGoogle Scholar
  121. 121.
    Yaksh RL (1981) Spinal opiate analgesia: characteristic and principles of actions. Pain 11: 293–346PubMedGoogle Scholar
  122. 122.
    Young RR, Delwaide PJ (1981) Drug therapy: spasticity. N Engl J Med 304: 96–99PubMedGoogle Scholar
  123. 123.
    Waltz JM, Reynolds LO, Riklan M (1981) Multi-lead spinal cord stimulation for control of motor disorders. Appl Neurophysiol 44: 244–257PubMedGoogle Scholar
  124. 124.
    Wang JK (1977) Analgesic effect of intrathecally administered morphine. Reg Anaesth 4: 2–3Google Scholar
  125. 125.
    Wang JK, Nauss LE, Thomas JE (1979) Pain relief by intrathecally applied morphine in man. Anaesthesiology 50: 149–151Google Scholar
  126. 126.
    Willer JC, Bussel B (1980) Evidence for a direct spinal mechanism in morphine-induced inhibition of nociceptive reflexes in humans. Brain Res 187: 212–217PubMedGoogle Scholar
  127. 127.
    Zenz H, Piepenbrock S, Hilfrich J, Husch M (1982) Pain therapy with epidural morphine in patients with terminal cancer. Spinal Opiate Analgesia 144: 141–144Google Scholar
  128. 128.
    Zieglgansberger W, Howe JR, Sutor B (1988) The neuropharmacology of baclofen: In: Müller H, Zierski J, Penn RD (eds) Local spinal therapy of spasticity. Springer, Berlin Heidelberg New York Tokyo, pp 37–49Google Scholar

Copyright information

© Springer-Verlag Wien 1991

Authors and Affiliations

  • Y. Lazorthes
    • 1
  • B. Sallerin-Caute
    • 1
  • J. C. Verdie
    • 1
  • R. Bastide
    • 1
  1. 1.University Neurosurgical Clinic, Medical Faculty of Rangueil, Université Paul SabatierToulouseFrance

Personalised recommendations